Antiviral Induced Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS) Dyndrome: A Literature Review
Abstract
Drug reaction with eosinophilia and systemic symptoms syndrome (DRESS) is a delayed infrequent potentially life-threatening drug reaction. Fever, rash, lymphadenopathy, eosinophilia, and hepatic involvement are common features. Aromatic anticonvulsants and allopurinol are the most frequent causative agents. However, some cases of antivirals induced DRESS are available. In this review, we try to summarize studies of antiviral induced DRESS syndrome. The data were collected by searching PubMed, Science Direct, Google Scholar, Scopus, Cochrane database systematic reviews, and Islamic World Science Citation Center (ISC). The Keywords used as search terms were “DRESS syndrome”, “drug-induced hypersensitivity reaction (DIHS)”, “antiviral”, and names of various antiviral agents. Finally, a total of 28 relevant articles up to the date of publication were included for review. Totally, 30 cases of antiviral induced DRESS are reported. European registry on severe cutaneous adverse drug reactions (RegiSCAR) was the usual used clinical diagnostic criteria. Most of the reports were related to, telaprevir. Rash and fever actually occurred in a large number of these patients. Eosinophilia was the most reported hematologic involvement. Liver injury is the most defined type of organ damage. Most of the patients managed with systemic corticosteroids. The death occurred in 1 patient from liver decompensation. The reactivation various viruses especially HHV-6 is reported in 2 Cases. The latency period was between 10 and 330 days after drug administration. It is necessary to perform more studies, especially those focused on the association between DRESS syndrome and viral reactivation and also its effective management.
1. Hatcher, Jain V, Victor G, Pierscianowski T. Piperacillin-Tazobactam–Induced Drug Hypersensitivity Syndrome. Cutis 2006;77(6):353-7.
2. Cabañas R, Calderon O, Ramirez E, et al. Piperacillin-induced DRESS: distinguishing features observed in a clinical and allergy study of 8 patients. J Investig Allergol Clin Immunol 2014;24(6):425-30
3. Cacoub P1, Musette P, Descamps V, et al. The DRESS syndrome: a literature review. Am J Med 2011;124(7):588-97.
4. Girelli F1, Bernardi S, Gardelli L, et al. A New Case of DRESS Syndrome Induced by Sulfasalazine and Triggered by Amoxicillin. Case Rep Rheumatol 2013;2013:409152.
5. Blumenthal KG, Patil SU, Long AA. The importance of vancomycin in drug rash with eosinophilia and systemic symptoms (DRESS) syndrome. Allergy Asthma Proc 2012;33(2):165-71.
6. Vauthey L, Uçkay I, Abrassart S, et al. Vancomycin-induced DRESS syndrome in a female patient. Pharmacology 2008;82(2):138-41
7. Artuković M, Kuštelega J, Lugović-Mihić L. DRESS syndrome with mild manifestations as a diagnostic and therapeutic problem: case report. Acta Clin Croat 2010;49(4):479-84.
8. Robles DT1, Leonard JL, Compton N, et al. Severe drug hypersensitivity reaction in a young woman treated with doxycycline. Dermatology 2008;217(1):23-6
9. Sharpe A, Mourad BM, Hardwick CJ, Reilly T, Dweck E, Bondarsky E. Oxacillin-Induced Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS). Am J Case Rep 2019;20:345-348
10. Littlehales E, Murray O, Dunsmuir R. Vancomycin-Induced DRESS Syndrome: An Important Concern in Orthopedic Surgery. Case Rep Orthop 2018;2018:1439073
11. Díaz-Mancebo R, Costero-Fernández O, Vega-Cabrera C, et al. Dress syndrome and acute tubulointerstitial nephritis after treatment with vancomycin and beta-lactams. Case report and literature review. Nefrología 2012;32(5):685-7.
12. Um SJ, Lee SK, Kim YH, et al. Clinical Features of Drug-Induced Hypersensitivity Syndrome in 38 Patients. J Investig Allergol Clin Immunol 2010;20(7):556-62.
13. Peyrière H1, Dereure O, Breton H, et al.Variability in the clinical pattern of cutaneous side‐effects of drugs with systemic symptoms: does a DRESS syndrome really exist? Br J Dermatol 2006;155(2):422-8.
14. Eshki M, Allanore L, Musette P, et al. Twelve-year analysis of severe cases of drug reaction with eosinophilia and systemic symptoms: a cause of unpredictable multiorgan failure. Arch Dermatol 2009;145(1):67-72.
15. Shiohara T, Iijima M, Ikezawa Z, Hashimoto K. The diagnosis of a DRESS syndrome has been sufficiently established on the basis of typical clinical features and viral reactivations. Br J Dermatol 2007;156(5):1083-4.
16. Miller Quidley A, Bookstaver PB, Gainey AB, Gainey MD. Fatal Clindamycin‐Induced Drug Rash with Eosinophilia and Systemic Symptoms (DRESS) Syndrome. Pharmacotherapy 2012;32(12):e387-92.
17. Peyrière H1, Dereure O, Breton H, et al. Variability in the clinical pattern of cutaneous side‐effects of drugs with systemic symptoms: does a DRESS syndrome really exist? Br J Dermatol 2006;155(2):422-8.
18. Pal A, Sen S, Biswas A, Naser SM, Tripathi SK. A rare case of DRESS syndrome caused by vancomycin. Journal of Acute Medicine 2015;5(3):74-76.
19. Jurado-Palomo J1, Cabañas R, Prior N, et al. Use of the lymphocyte transformation test in the diagnosis of DRESS syndrome induced by ceftriaxone and piperacillin-tazobactam: two case reports. J Investig Allergol Clin Immunol 2010;20(5):433-6.
20. Barbaud A, Collet E, Milpied B, et al. A multicentre study to determine the value and safety of drug patch tests for the three main classes of severe cutaneous adverse drug reactions. Br J Dermatol 2013;168(3):555-62.
21. Bensaid B, Rozieres A, Nosbaum A, Nicolas JF, Berard F. Amikacin-induced drug reaction with eosinophilia and systemic symptoms syndrome: delayed skin test and ELISPOT assay results allow the identification of the culprit drug. J Allergy Clin Immunol 2012;130(6):1413-4.
22. Mousa OY, Khalaf R, Shannon RL, Egwim CI, Zela SA, Ankoma-Sey V. Chronic Hepatitis C Therapy in Liver Cirrhosis Complicated by Telaprevir-Induced DRESS. Case Rep Med 2014;2014:380424.
23. Allouchery M, Logerot S, Cottin J, et al. Antituberculosis Drug-Associated DRESS: A Case Series. J Allergy Clin Immunol Pract 2018;6(4):1373-80.
24. Aouam K1, Chaabane A, Toumi A, et al. Drug rash with eosinophilia and systemic symptoms (DRESS) probably induced by cefotaxime: a report of two cases. Clin Med Res 2012;10(1):32-5.
25. Hagihara M, Yamagishi Y, Hirai J, et al. Drug-induced hypersensitivity syndrome by liposomal amphotericin-B: a case report. BMC Res Notes 2015;8:510.
26. Descamps V, Valance A, Edlinger C, et al. Association of human herpesvirus 6 infection with drug reaction with eosinophilia and systemic symptoms. Arch Dermatol 2001;137(3):301-4.
27. Kanno K, Sakai H, Yamada Y, Iizuka H. Drug-induced hypersensitivity syndrome due to minocycline complicated by severe myocarditis. J Dermatol 2014;41(2):160-2.
28. Tian D, Mohan RJ, Stallings G. Drug rash with eosinophilia and systemic symptoms syndrome associated with clindamycin. Am J Med 2010;123(11):e7-8.
29. Brown RJ1, Rother KI, Artman H, et al. Minocycline-induced drug hypersensitivity syndrome followed by multiple autoimmune sequelae. Arch Dermatol 2009;145(1):63-6.
30. Cengiz FP, Su O, Emiroglu N, Biyik Ozkaya D, Bahali AG, Onsun N. A rare and severe cutaneous adverse effect of telaprevir: drug rash with eosinophilia and systemic symptoms. G Ital Dermatol Venereol 2019;154(4):488-491.
31. Akar T, Kilavuz B, Malkoç D, Dindar G, Aynioğlu A. Telaprevir-Induced DRESS Syndrome Associated With Salmonella typhi. ACG Case Rep J 2015;2(2):79-80.
32. Kömür S, Ulu A, Kurtaran B, İnal AS, Taşova Y, Aksu HS. Telaprevir-related DRESS syndrome complicating hepatitis C treatment. Journal of Microbiology and Infectious Diseases 2015;5(01):36-7.
33. Samain A, Duval-Modeste AB, Joly P, et al. First case of drug rash eosinophilia and systemic symptoms due to boceprevir. J Hepatol 2014;60(4):891-3.
34. Calza L, Rosseti N, Biagetti C, Pocaterra D, Colangeli V, Manfredi R. Abacavir-induced reaction with fever and severe skin rash in a patient tested human leukocyte antigen-B*5701 negative. Int J STD AIDS 2009;20(4):276-7.
35. Aqtash O, Ajmeri AN, Thornhill BA, et al. A Unique Case Of Tenofovir-Induced DRESS Syndrome Associated With Raynaud’s Of The Tongue. Int J Gen Med 2019;12:381-5.
36. Thomas M, Hopkins C, Duffy E, Loulergue P, Ripamonti D, Lee D.The HLA-B* 53/HLA-C* 04 Haplotype is Strongly Associated with DRESS Syndrome during Treatment with Raltegravir. Open Forum Infectious Diseases 2016;3(Suppl 1):1510
37. Martin C, Payen MC, De Wit S. Dolutegravir as a trigger for DRESS syndrome? Int J STD AIDS 2018;29(10):1036-8.
38. Lanzafame M, Rovere P, De Checchi G, Trevenzoli M, Turazzini M, Parrinello A. Hypersensitivity syndrome (DRESS) and meningoencephalitis associated with nevirapine therapy. Scand J Infect Dis 2001;33(6):475-6.
39. Pott Junior H, Gosuen GC, Gales AC. DRESS Syndrome due to Nevirapine Treated with Methylprednisolone. Case Rep Med 2013;2013:269501.
40. Santos RP, Ramilo O, Barton T. Nevirapine-associated rash with eosinophilia and systemic symptoms in a child with human immunodeficiency virus infection. Pediatr Infect Dis J 2007;26(11): 1053-6.
41. Keohane C, Bacon CL, Moran B, Irvine AD, Smith OP. Drug rash with eosinophilia and systemic symptoms (DRESS) syndrome induced by cidofovir. Pediatr Transplant 2011;15(1):121.
42. Descamps V. Drug reaction with eosinophilia and systemic symptoms (DRESS) induced by cidofovir in a transplant recipient: a misunderstanding of DRESS. Pediatr Transplant 2011;15(4):443-4.
43. Lee JY, Seol YJ, Shin DW. A Case of the Drug Reaction with Eosinophilia and Systemic Symptom (DRESS) Following Isoniazid Treatment. Tuberc Respir Dis (Seoul) 2015;78(1): 27-30.
44. Velema MS, Voerman HJ. DRESS syndrome caused by nitrofurantoin. Neth J Med 2009;67(4): 147-9.
45. Boet S, Noblet C, Haas-Hubscher C, Picard D, Musette P, Dureuil B. Severe vancomycin-induced drug rash with eosinophilia and systemic symptoms syndrome imitating septic shock. Eur J Anaesthesiol 2009;26(9):791-3.
46. Miyazu D, Kodama N, Yamashita D. DRESS Syndrome Caused by Cross-reactivity Between Vancomycin and Subsequent Teicoplanin Administration: A Case Report. Am J Case Rep 2016;17:625-31.
47. Karakayalı B, Yazar AS, Çakir D, et al. Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS) syndrome associated with cefotaxime and clindamycin use in a 6-year-old boy: a case report. Pan Afr Med J 2017;28:218.
48. Almudimeegh A, Rioux C, Ferrand H, Crickx B, Yazdanpanah Y, Descamps V. Drug reaction with eosinophilia and systemic symptoms, or virus reactivation with eosinophilia and systemic symptoms as a manifestation of immune reconstitution inflammatory syndrome in a patient with HIV? Br J Dermatol 2014;171(4):895-8.
49. Zhang KS, Modi GM, Hsu S. DRESS syndrome associated with raltegravir. Dermatol Online J 2011;17(8):14.
50. Loulergue P, Mir O. Raltegravir-induced DRESS syndrome. Scand J Infect Dis 2012;44(10):802-3.
51. Perry ME1, Almaani N, Desai N, Larbalestier N, Fox J, Chilton D. Raltegravir-induced Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS) syndrome- implications for clinical practice and patient safety. Int J STD AIDS 2013;24(8):639-42.
52. Yee BE, Nguyen NH, Lee D (2014) Extensive pulmonary involvement with raltegravir-induced DRESS syndrome in a postpartum woman with HIV. BMJ Case Rep 2014;2014:bcr2013201545.
53. Scaggs FA, Aziz MS, Palmisano EL, Mahdavinia M, Raikar SS, Logan LK. Raltegravir-induced drug reaction with eosinophilia and systemic symptoms syndrome in a child. Ann Allergy Asthma Immunol 2016;117(6):719-721.
54. Bourezane Y1, Salard D, Hoen B, Vandel S, Drobacheff C, Laurent R. DRESS (Drug Rash with Eosinophilia and Systemic Syndrome Associated with Nevirapine Therapy. Clin Infect Dis 1998;27(5):1321-2.
55. Breining A, Guihot A, Warot D, et al. Persistent high nevirapine blood level with DRESS syndrome 12 days after interruption of antiretroviral therapy. BMJ Case Rep 2009;2009:bcr0720080475.
56. Gill S, Sagar A, Shankar S, Nair V. Nevirapine-induced rash with eosinophilia and systemic symptoms (DRESS). Indian J Pharmacol 2013;45(4):401-2.
57. Reghukumar A, Gurudas A, Kumar VK, Ravi R. Autoimmune hemolytic anemia as part of Nevirapine induced DRESS syndrome. BMC Infectious Diseases 2014;14(Suppl 3):68.
58. Janocha-Litwin J, Pazgan-Simon M, Simon K. DRESS syndrome as a complication of treatment of hepatitis C virus-associated post-inflammatory liver cirrhosis with peginterferon alpha2a and ribavirin. Postepy Dermatol Alergol 2014;31(6):401-4.
59. Montaudié H, Passeron T, Cardot-Leccia N, Sebbag N, Lacour JP. Drug rash with eosinophilia and systemic symptoms due to telaprevir. Dermatology 2010;221(4):303-5.
60. Kesar V, Kesar V, Khaitova V, Motamed D, Schiano T.Telaprevir-induced DRESS. J Drugs Dermatol 2014;13(2):199-200.
61. Gonzalez Quesada A, Medina Gil C, Castro Gonzalez E, Quinones I, Castano Gonzalez I, Vilar Alejo J. DRESS syndrome caused by telaprevir: A case report. J Am Acad Dermatol 2014;70:AB42.
62. Broccolo F, Ciccarese G, Picciotto A, Drago F. A case of drug rash with eosinophilia and systemic symptoms (DRESS) induced by telaprevir associated with HHV-6 active infection. J Hepatol 2015;62(1):248-9.
63. Shuster M, Do D, Nambudiri V. Severe cutaneous adverse reaction to telaprevir. Dermatol Online J 2015;21(1): pii: 13030/qt2zq8z9zt..
2. Cabañas R, Calderon O, Ramirez E, et al. Piperacillin-induced DRESS: distinguishing features observed in a clinical and allergy study of 8 patients. J Investig Allergol Clin Immunol 2014;24(6):425-30
3. Cacoub P1, Musette P, Descamps V, et al. The DRESS syndrome: a literature review. Am J Med 2011;124(7):588-97.
4. Girelli F1, Bernardi S, Gardelli L, et al. A New Case of DRESS Syndrome Induced by Sulfasalazine and Triggered by Amoxicillin. Case Rep Rheumatol 2013;2013:409152.
5. Blumenthal KG, Patil SU, Long AA. The importance of vancomycin in drug rash with eosinophilia and systemic symptoms (DRESS) syndrome. Allergy Asthma Proc 2012;33(2):165-71.
6. Vauthey L, Uçkay I, Abrassart S, et al. Vancomycin-induced DRESS syndrome in a female patient. Pharmacology 2008;82(2):138-41
7. Artuković M, Kuštelega J, Lugović-Mihić L. DRESS syndrome with mild manifestations as a diagnostic and therapeutic problem: case report. Acta Clin Croat 2010;49(4):479-84.
8. Robles DT1, Leonard JL, Compton N, et al. Severe drug hypersensitivity reaction in a young woman treated with doxycycline. Dermatology 2008;217(1):23-6
9. Sharpe A, Mourad BM, Hardwick CJ, Reilly T, Dweck E, Bondarsky E. Oxacillin-Induced Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS). Am J Case Rep 2019;20:345-348
10. Littlehales E, Murray O, Dunsmuir R. Vancomycin-Induced DRESS Syndrome: An Important Concern in Orthopedic Surgery. Case Rep Orthop 2018;2018:1439073
11. Díaz-Mancebo R, Costero-Fernández O, Vega-Cabrera C, et al. Dress syndrome and acute tubulointerstitial nephritis after treatment with vancomycin and beta-lactams. Case report and literature review. Nefrología 2012;32(5):685-7.
12. Um SJ, Lee SK, Kim YH, et al. Clinical Features of Drug-Induced Hypersensitivity Syndrome in 38 Patients. J Investig Allergol Clin Immunol 2010;20(7):556-62.
13. Peyrière H1, Dereure O, Breton H, et al.Variability in the clinical pattern of cutaneous side‐effects of drugs with systemic symptoms: does a DRESS syndrome really exist? Br J Dermatol 2006;155(2):422-8.
14. Eshki M, Allanore L, Musette P, et al. Twelve-year analysis of severe cases of drug reaction with eosinophilia and systemic symptoms: a cause of unpredictable multiorgan failure. Arch Dermatol 2009;145(1):67-72.
15. Shiohara T, Iijima M, Ikezawa Z, Hashimoto K. The diagnosis of a DRESS syndrome has been sufficiently established on the basis of typical clinical features and viral reactivations. Br J Dermatol 2007;156(5):1083-4.
16. Miller Quidley A, Bookstaver PB, Gainey AB, Gainey MD. Fatal Clindamycin‐Induced Drug Rash with Eosinophilia and Systemic Symptoms (DRESS) Syndrome. Pharmacotherapy 2012;32(12):e387-92.
17. Peyrière H1, Dereure O, Breton H, et al. Variability in the clinical pattern of cutaneous side‐effects of drugs with systemic symptoms: does a DRESS syndrome really exist? Br J Dermatol 2006;155(2):422-8.
18. Pal A, Sen S, Biswas A, Naser SM, Tripathi SK. A rare case of DRESS syndrome caused by vancomycin. Journal of Acute Medicine 2015;5(3):74-76.
19. Jurado-Palomo J1, Cabañas R, Prior N, et al. Use of the lymphocyte transformation test in the diagnosis of DRESS syndrome induced by ceftriaxone and piperacillin-tazobactam: two case reports. J Investig Allergol Clin Immunol 2010;20(5):433-6.
20. Barbaud A, Collet E, Milpied B, et al. A multicentre study to determine the value and safety of drug patch tests for the three main classes of severe cutaneous adverse drug reactions. Br J Dermatol 2013;168(3):555-62.
21. Bensaid B, Rozieres A, Nosbaum A, Nicolas JF, Berard F. Amikacin-induced drug reaction with eosinophilia and systemic symptoms syndrome: delayed skin test and ELISPOT assay results allow the identification of the culprit drug. J Allergy Clin Immunol 2012;130(6):1413-4.
22. Mousa OY, Khalaf R, Shannon RL, Egwim CI, Zela SA, Ankoma-Sey V. Chronic Hepatitis C Therapy in Liver Cirrhosis Complicated by Telaprevir-Induced DRESS. Case Rep Med 2014;2014:380424.
23. Allouchery M, Logerot S, Cottin J, et al. Antituberculosis Drug-Associated DRESS: A Case Series. J Allergy Clin Immunol Pract 2018;6(4):1373-80.
24. Aouam K1, Chaabane A, Toumi A, et al. Drug rash with eosinophilia and systemic symptoms (DRESS) probably induced by cefotaxime: a report of two cases. Clin Med Res 2012;10(1):32-5.
25. Hagihara M, Yamagishi Y, Hirai J, et al. Drug-induced hypersensitivity syndrome by liposomal amphotericin-B: a case report. BMC Res Notes 2015;8:510.
26. Descamps V, Valance A, Edlinger C, et al. Association of human herpesvirus 6 infection with drug reaction with eosinophilia and systemic symptoms. Arch Dermatol 2001;137(3):301-4.
27. Kanno K, Sakai H, Yamada Y, Iizuka H. Drug-induced hypersensitivity syndrome due to minocycline complicated by severe myocarditis. J Dermatol 2014;41(2):160-2.
28. Tian D, Mohan RJ, Stallings G. Drug rash with eosinophilia and systemic symptoms syndrome associated with clindamycin. Am J Med 2010;123(11):e7-8.
29. Brown RJ1, Rother KI, Artman H, et al. Minocycline-induced drug hypersensitivity syndrome followed by multiple autoimmune sequelae. Arch Dermatol 2009;145(1):63-6.
30. Cengiz FP, Su O, Emiroglu N, Biyik Ozkaya D, Bahali AG, Onsun N. A rare and severe cutaneous adverse effect of telaprevir: drug rash with eosinophilia and systemic symptoms. G Ital Dermatol Venereol 2019;154(4):488-491.
31. Akar T, Kilavuz B, Malkoç D, Dindar G, Aynioğlu A. Telaprevir-Induced DRESS Syndrome Associated With Salmonella typhi. ACG Case Rep J 2015;2(2):79-80.
32. Kömür S, Ulu A, Kurtaran B, İnal AS, Taşova Y, Aksu HS. Telaprevir-related DRESS syndrome complicating hepatitis C treatment. Journal of Microbiology and Infectious Diseases 2015;5(01):36-7.
33. Samain A, Duval-Modeste AB, Joly P, et al. First case of drug rash eosinophilia and systemic symptoms due to boceprevir. J Hepatol 2014;60(4):891-3.
34. Calza L, Rosseti N, Biagetti C, Pocaterra D, Colangeli V, Manfredi R. Abacavir-induced reaction with fever and severe skin rash in a patient tested human leukocyte antigen-B*5701 negative. Int J STD AIDS 2009;20(4):276-7.
35. Aqtash O, Ajmeri AN, Thornhill BA, et al. A Unique Case Of Tenofovir-Induced DRESS Syndrome Associated With Raynaud’s Of The Tongue. Int J Gen Med 2019;12:381-5.
36. Thomas M, Hopkins C, Duffy E, Loulergue P, Ripamonti D, Lee D.The HLA-B* 53/HLA-C* 04 Haplotype is Strongly Associated with DRESS Syndrome during Treatment with Raltegravir. Open Forum Infectious Diseases 2016;3(Suppl 1):1510
37. Martin C, Payen MC, De Wit S. Dolutegravir as a trigger for DRESS syndrome? Int J STD AIDS 2018;29(10):1036-8.
38. Lanzafame M, Rovere P, De Checchi G, Trevenzoli M, Turazzini M, Parrinello A. Hypersensitivity syndrome (DRESS) and meningoencephalitis associated with nevirapine therapy. Scand J Infect Dis 2001;33(6):475-6.
39. Pott Junior H, Gosuen GC, Gales AC. DRESS Syndrome due to Nevirapine Treated with Methylprednisolone. Case Rep Med 2013;2013:269501.
40. Santos RP, Ramilo O, Barton T. Nevirapine-associated rash with eosinophilia and systemic symptoms in a child with human immunodeficiency virus infection. Pediatr Infect Dis J 2007;26(11): 1053-6.
41. Keohane C, Bacon CL, Moran B, Irvine AD, Smith OP. Drug rash with eosinophilia and systemic symptoms (DRESS) syndrome induced by cidofovir. Pediatr Transplant 2011;15(1):121.
42. Descamps V. Drug reaction with eosinophilia and systemic symptoms (DRESS) induced by cidofovir in a transplant recipient: a misunderstanding of DRESS. Pediatr Transplant 2011;15(4):443-4.
43. Lee JY, Seol YJ, Shin DW. A Case of the Drug Reaction with Eosinophilia and Systemic Symptom (DRESS) Following Isoniazid Treatment. Tuberc Respir Dis (Seoul) 2015;78(1): 27-30.
44. Velema MS, Voerman HJ. DRESS syndrome caused by nitrofurantoin. Neth J Med 2009;67(4): 147-9.
45. Boet S, Noblet C, Haas-Hubscher C, Picard D, Musette P, Dureuil B. Severe vancomycin-induced drug rash with eosinophilia and systemic symptoms syndrome imitating septic shock. Eur J Anaesthesiol 2009;26(9):791-3.
46. Miyazu D, Kodama N, Yamashita D. DRESS Syndrome Caused by Cross-reactivity Between Vancomycin and Subsequent Teicoplanin Administration: A Case Report. Am J Case Rep 2016;17:625-31.
47. Karakayalı B, Yazar AS, Çakir D, et al. Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS) syndrome associated with cefotaxime and clindamycin use in a 6-year-old boy: a case report. Pan Afr Med J 2017;28:218.
48. Almudimeegh A, Rioux C, Ferrand H, Crickx B, Yazdanpanah Y, Descamps V. Drug reaction with eosinophilia and systemic symptoms, or virus reactivation with eosinophilia and systemic symptoms as a manifestation of immune reconstitution inflammatory syndrome in a patient with HIV? Br J Dermatol 2014;171(4):895-8.
49. Zhang KS, Modi GM, Hsu S. DRESS syndrome associated with raltegravir. Dermatol Online J 2011;17(8):14.
50. Loulergue P, Mir O. Raltegravir-induced DRESS syndrome. Scand J Infect Dis 2012;44(10):802-3.
51. Perry ME1, Almaani N, Desai N, Larbalestier N, Fox J, Chilton D. Raltegravir-induced Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS) syndrome- implications for clinical practice and patient safety. Int J STD AIDS 2013;24(8):639-42.
52. Yee BE, Nguyen NH, Lee D (2014) Extensive pulmonary involvement with raltegravir-induced DRESS syndrome in a postpartum woman with HIV. BMJ Case Rep 2014;2014:bcr2013201545.
53. Scaggs FA, Aziz MS, Palmisano EL, Mahdavinia M, Raikar SS, Logan LK. Raltegravir-induced drug reaction with eosinophilia and systemic symptoms syndrome in a child. Ann Allergy Asthma Immunol 2016;117(6):719-721.
54. Bourezane Y1, Salard D, Hoen B, Vandel S, Drobacheff C, Laurent R. DRESS (Drug Rash with Eosinophilia and Systemic Syndrome Associated with Nevirapine Therapy. Clin Infect Dis 1998;27(5):1321-2.
55. Breining A, Guihot A, Warot D, et al. Persistent high nevirapine blood level with DRESS syndrome 12 days after interruption of antiretroviral therapy. BMJ Case Rep 2009;2009:bcr0720080475.
56. Gill S, Sagar A, Shankar S, Nair V. Nevirapine-induced rash with eosinophilia and systemic symptoms (DRESS). Indian J Pharmacol 2013;45(4):401-2.
57. Reghukumar A, Gurudas A, Kumar VK, Ravi R. Autoimmune hemolytic anemia as part of Nevirapine induced DRESS syndrome. BMC Infectious Diseases 2014;14(Suppl 3):68.
58. Janocha-Litwin J, Pazgan-Simon M, Simon K. DRESS syndrome as a complication of treatment of hepatitis C virus-associated post-inflammatory liver cirrhosis with peginterferon alpha2a and ribavirin. Postepy Dermatol Alergol 2014;31(6):401-4.
59. Montaudié H, Passeron T, Cardot-Leccia N, Sebbag N, Lacour JP. Drug rash with eosinophilia and systemic symptoms due to telaprevir. Dermatology 2010;221(4):303-5.
60. Kesar V, Kesar V, Khaitova V, Motamed D, Schiano T.Telaprevir-induced DRESS. J Drugs Dermatol 2014;13(2):199-200.
61. Gonzalez Quesada A, Medina Gil C, Castro Gonzalez E, Quinones I, Castano Gonzalez I, Vilar Alejo J. DRESS syndrome caused by telaprevir: A case report. J Am Acad Dermatol 2014;70:AB42.
62. Broccolo F, Ciccarese G, Picciotto A, Drago F. A case of drug rash with eosinophilia and systemic symptoms (DRESS) induced by telaprevir associated with HHV-6 active infection. J Hepatol 2015;62(1):248-9.
63. Shuster M, Do D, Nambudiri V. Severe cutaneous adverse reaction to telaprevir. Dermatol Online J 2015;21(1): pii: 13030/qt2zq8z9zt..
| Files | ||
| Issue | Vol 8, No 1 (Winter 2020) | |
| Section | Review Article(s) | |
| DOI | https://doi.org/10.18502/jpc.v8i1.2745 | |
| Keywords | ||
| DRESS Syndrome; Drug-Induced Hypersensitivity Syndrome (DIHS) Antiviral | ||
| Rights and permissions | |
|
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |
How to Cite
1.
Sharifzadeh S, Elyasi S, Mohammadpour AH. Antiviral Induced Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS) Dyndrome: A Literature Review. J Pharm Care. 2020;8(1):35-47.
